quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:01:00·171d
PRRelease
Mind Medicine (MindMed) Inc. logo

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

MNMD· Mind Medicine (MindMed) Inc.
Health Care
Original source

Companies

  • MNMD
    Mind Medicine (MindMed) Inc.
    Health Care

Recent analyst ratings

  • Oct 13UpdateNeedham$28.00
  • Aug 4UpdateOppenheimer$25.00
  • Jan 28UpdateEvercore ISI$23.00
  • Dec 20UpdateChardan Capital Markets$20.00
  • Oct 14UpdateLeerink Partners$20.00
  • Jul 24UpdateROTH MKM$36.00

Related

  • SEC101d
    Mind Medicine (MindMed) Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
  • INSIDER115d
    Chief Legal Officer Sullivan Mark sold $148,244 worth of shares (11,276 units at $13.15), decreasing direct ownership by 4% to 282,576 units (SEC Form 4)
  • INSIDER115d
    Chief Executive Officer Barrow Robert sold $339,072 worth of shares (25,791 units at $13.15), decreasing direct ownership by 3% to 778,477 units (SEC Form 4)
  • INSIDER115d
    Chief Medical Officer Karlin Daniel sold $73,623 worth of shares (5,600 units at $13.15), decreasing direct ownership by 1% to 425,025 units (SEC Form 4)
  • SEC115d
    SEC Form 144 filed by Mind Medicine (MindMed) Inc.
  • PR126d
    MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference
  • PR129d
    MindMed Announces New Employee Inducement Grant
  • PR143d
    MindMed Announces New Employee Inducement Grants
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022